Head of US, Global Real-World Evidence & Health Outcomes Research

If you are an employee potentially impacted and at risk of redundancy, please add the following statement at the top of your CV: ‘At Risk of Redundancy’.

GlaxoSmithKline (GSK) is a global healthcare company committed to improving the quality of human life by enabling people to do more, feel better, and live longer. We discover, develop, and deliver innovative medicines, vaccines, and consumer healthcare products, and we are dedicated to our mission of helping people around the world.  

At GSK, we are dedicated to creating an inclusive and diverse workplace that reflects the communities we serve. We offer competitive compensation and benefits packages, opportunities for professional development, and a culture that values innovation, collaboration, and integrity.  

The Chief Patient Organization led by the Chief Patient Officer is accountable for bringing external perspectives of thought leaders, academic institutions, and patient groups, along with internal insights, to elevate the patient voice and shape company strategy. This means GSK will deliver differentiated vaccines and medicines that address the unmet needs of people around the world - better and faster.   

The Head of US, Global Real-World Evidence & Health Outcomes Research will be the overall leader of the non-interventional data generation team for the US business.  Accountabilities include management and development of a team of leaders and scientists with expertise in real-world evidence and other non-interventional study methods. This role will ensure that team members engage closely with US and global medical teams and other matrix stakeholders and partners to plan and design data generation plans (DGPs) for priority assets across the US business, drive disciplined execution of studies and activities, translate results and disseminate data and research findings to all relevant internal and external stakeholders.   

Head of US, Global Real-World Evidence & Health Outcomes Research will lead the US team to deliver relevant, innovative and high impact evidence to meet the needs of external stakeholders such as health care professionals, scientific communities, Health Technology Assessment (HTA) and recommending bodies, patient and advocacy groups and other material stakeholders. The role will work with senior cross-functional leadership in medical affairs, market access, commercial, LoCs to ensure deliverables from this team are strategically aligned, transparent and timely. This role will ensure evidence generation projects conducted by this team comply with GSK SOPs and external regulatory and research standards.  

This role will bring together and consolidate pre-existing teams and will need a clear vision of how to structure and build these groups for the future. This includes development of NIS research capability, harnessing new and exciting innovations, optimizing resources in alignment with portfolio priorities and ensure capacity to deliver endorsed evidence generation strategies and plans. The role presents a unique opportunity to shape something new, setting a high bar in the structuring and future delivery of non-interventional research for the US business. This role will require active engagement with other senior leaders, external thought partners and will need to exert significant influence across a diverse range of stakeholders both internal and external.

This role will provide YOU the opportunity to lead key activities to progress YOUR career, these responsibilities include some of the following…

Provide leadership, management, and development of the therapy area team, including recruitment and capability building, support, and improvement opportunities through best practice sharing to create high performing, quality assured resources which support the business .

Provide advice and guidance for best practice in evidence methodologies, including enabling external scientific advice, ensuring appropriate protocol review committee’s advice sought and incorporated.  

Drive innovation across the TA, inform ideas and options through effective engagement with external experts, HTA agencies,